C. Ann Merrifield, Director at Flexion Therapeutics Inc (FLXN), bought 1,000 shares at $13.39 ($13K) on 2016-06-14, disclosed to the SEC on 2016-06-16.
Open-market purchase of $13k FLXN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| LYRA | BUY | 2021-06-22 | $31K | — | Filing → |
| FLXN | BUY | 2019-05-24 | $101K | — | Filing → |
| JNP | BUY | 2016-08-29 | $11K | — | Filing → |